Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Daryl Scott Lab, |
RCV002245300 | SCV002515360 | uncertain significance | Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome | 2022-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004045184 | SCV005005635 | uncertain significance | Inborn genetic diseases | 2021-08-13 | criteria provided, single submitter | clinical testing | The c.1600C>T (p.R534C) alteration is located in exon 14 (coding exon 14) of the MSTO1 gene. This alteration results from a C to T substitution at nucleotide position 1600, causing the arginine (R) at amino acid position 534 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |